IPP Bureau
Albumedix and Valneva expand collaboration to include newly approved inactivated Covid-19 vaccine
By IPP Bureau - April 18, 2022
This marks an expansion of the companies' existing collaboration and further validates the use of Albumedix Recombumin rHA products in the manufacturing process and final formulation of critical vaccines
Amneal achieves second U.S. biosimilars approval with Alymsys
By IPP Bureau - April 18, 2022
Marks the second of three biosimilars Amneal expects to receive U.S. approval for in 2022
GSK to acquire Sierra Oncology for US $1.9bn
By IPP Bureau - April 18, 2022
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
Geocann and Averix Bio to partner on API phytocannabinoid ingredients
By IPP Bureau - April 18, 2022
This partnership allows both companies to become first movers to bridge an inevitable gap with the largest organizations in the pharmaceutical, nutraceutical, cosmetic, and veterinary sectors
Sanofi India appoints Rodolfo Hrosz as new Managing Director
By IPP Bureau - April 18, 2022
Rodolfo brings with him a wealth of rich experience from commercial, marketing, and general management roles across several multinational companies
Fujifilm India completes installation of 50,000 medical devices in India
By IPP Bureau - April 18, 2022
Fujifilm’s NEVER STOP philosophy to enhance the access to healthcare for all Indians
Ministry of Health and Family Welfare (MoHFW) organises Health Mela
By IPP Bureau - April 18, 2022
These melas serve as platforms to attract thousands of people to avail quality healthcare services along with essential medicines and diagnostic services
Lupin receives tentative approval from USFDA for Tenofovir Alafenamide Tablets
By IPP Bureau - April 18, 2022
This product will be manufactured at Lupin’s Nagpur facility in India
Apollo Hospitals and Healthium Medtech launch advanced training at Apollo Simulation Centre
By IPP Bureau - April 18, 2022
The initial courses of Lap. Hernia Masterclass will encompass commonly performed hernia procedures
Zydus Lifesciences receives final approval from USFDA for Cyanocobalamin Injection
By IPP Bureau - April 18, 2022
The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat
PM to inaugurate WHO Global Centre for Traditional Medicine at Jamanagar on April 19
By IPP Bureau - April 18, 2022
The Centre aims to channel the potential of traditional medicine by integrating it with technological advancements and evidence-based research
Trivitron Healthcare sets up ultrasound manufacturing facility in India
By IPP Bureau - April 17, 2022
The ultrasound products manufactured in the new manufacturing facility will be sold under the brand name SonoRad, and are designed for large hospitals, healthcare institutions and individual radiology centres
Dr. Mansukh Mandaviya chairs celebrations of Ayushman Bharat health and wellness centres
By IPP Bureau - April 17, 2022
Dr. Mansukh Mandaviya launches a quarterly report on AB-HWCs, Guidelines on Human resources for health, Public Health Management Cadre’ Guidance for implementation and Indian Public Health Standards Guidelines; interacts with healthcare workers from across the country
Signia launches its first hearing impairment store in Delhi
By IPP Bureau - April 17, 2022
First of its kind interactive concept store ‘Brilliant Sound Galaxy (BSG)’ in the capital city
PLI scheme to achieve Aatma Nirbhar Bharat: Dr Manshukh Mandaviya
By IPP Bureau - April 17, 2022
The minister exhorted the pharmaceutical sector to prepare a plan for the next 25 years
